Best Ovarian Cancer Doctors in Hyderabad — CION's Dedicated Gynae-Oncology Panel
Choosing an ovarian cancer doctor is the single most consequential decision you will make in this journey — and for ovarian cancer specifically, the first surgery determines almost everything that follows. CION operates Hyderabad's dedicated ovarian cancer panel across 11 city locations, with female specialists across surgical, medical, and radiation oncology, working together as a multidisciplinary tumour board on every case.
- Onco-trained surgical team — every ovarian cancer surgery performed by a gynae-oncology surgeon, never a general gynaecologist
- Female specialists available — across surgical, medical & radiation oncology — request a female specialist at booking
- PARP inhibitor maintenance — olaparib · niraparib · rucaparib for BRCA-mutated & platinum-sensitive disease
- Fertility preservation discussed upfront — raised at the first consultation, not after surgery
on Panel
Survival Rate*
Treated
(800+ reviews)
16 specialists, one team. Female specialists in every subspecialty.
Surgical, medical, and radiation oncology — with female specialists in every subspecialty for women who prefer them. Patients can request a female specialist when booking. Use the tabs to filter by specialty; request a specific doctor by name when booking.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Which Type of Doctor Actually Treats Ovarian Cancer?
Ovarian cancer is the cancer where the wrong first specialist most consistently leads to inadequate surgery. Many women first see a general gynaecologist — usually for unrelated symptoms or what is thought to be a benign cyst — and are operated on without onco-surgical training. Research consistently shows this leads to incomplete cytoreduction, the single biggest predictor of poor long-term outcomes. The good news is that this is entirely avoidable once you know which specialist to insist on.
| Specialist | What they treat | When you need them for ovarian cancer |
|---|---|---|
| General Gynaecologist / OB-GYN | Routine reproductive health — periods, contraception, pregnancy, fibroids, benign cysts | The most important warning on this page: a general gynaecologist is NOT the right doctor for ovarian cancer. They may detect a suspicious mass — but for surgery and treatment, you need an oncology-trained surgeon. |
| Gynaecologic Oncologist / Surgical Oncologist | Surgery for ovarian, uterine, cervical, and other gynaecological cancers — with onco-specific training | The right surgeon for ovarian cancer — trained in complete cytoreduction, lymph node dissection, omentectomy, and where needed bowel resection. Research consistently shows better outcomes than general gynaecology surgery. |
| Medical Oncologist | Systemic cancer treatment — chemotherapy, targeted therapy, PARP inhibitor maintenance | Essential for first-line carboplatin-paclitaxel chemo, BRCA-tailored PARP inhibitor maintenance, and management of recurrent disease. |
| Radiation Oncologist | Radiation therapy | Limited role in primary ovarian cancer treatment, but valuable for symptom control, recurrence, and certain rare subtypes. |
| Genetic Counsellor | Hereditary cancer risk assessment, BRCA and Lynch syndrome testing, family screening guidance | Recommended for every woman diagnosed with ovarian cancer per current NCCN guidelines — not just those with family history. CION offers genetic counselling as part of ovarian cancer care. |
| Reproductive Endocrinologist | Fertility preservation — oocyte freezing, ovarian tissue cryopreservation | A partner specialist for young women considering fertility preservation before cancer treatment begins. CION coordinates referral to accredited fertility centres where indicated. |
Which specialist should you see first?
Use this as a quick guide. Your specific situation may vary; any CION oncologist can review your case in 45 minutes and tell you which subspecialty should lead your care.
- Persistent bloating, pelvic pain, or post-menopausal bleedingStart with a gynaecologist for evaluation. If imaging shows a suspicious mass, ask for immediate referral to gynae-oncology.
- Ovarian mass detected on imagingGo directly to a surgical oncologist or gynae-oncologist. Do not let a general gynaecologist operate on a suspicious mass.
- Ovarian cancer confirmed, surgery plannedSurgical oncologist with gynae-oncology training leads. Tumour board reviews resectability and surgical approach.
- Advanced-stage disease, surgery not safe upfrontMedical oncologist leads neoadjuvant chemotherapy. Interval debulking surgery is planned after response assessment.
- Young woman, fertility a concernInsist on fertility preservation discussion at the first consultation. Reproductive endocrinology referral is coordinated where indicated.
- Family history of ovarian or breast cancerAdd genetic counselling. BRCA1, BRCA2, and Lynch syndrome testing is offered to every ovarian cancer patient at CION per NCCN guidelines.
The honest answer is that ovarian cancer requires a coordinated team — not a single doctor, however senior. The decision that matters most is choosing the team.
Seven Questions to Ask Before You Choose an Ovarian Cancer Doctor
Most women diagnosed with ovarian cancer arrive at their first consultation already shocked — by the diagnosis, by how advanced it is, and by how little anyone seems to have suspected it. The instinct is to start treatment immediately, often at whichever hospital first found the mass. That is the wrong instinct. Ovarian cancer is the cancer where the first decisions — about which surgeon operates, about whether fertility is preserved, about whether genetic testing happens — most decisively shape everything that follows.
How many ovarian cancer cases does this team treat in a year — and how many will be personally led by my doctor?
Ovarian cancer is uncommon. A general gynaecology practice may see only one or two cases a year. Volume creates the pattern recognition this cancer demands — especially around the difference between operable, advanced, and platinum-sensitive disease.
If I want to have children later, can my treatment preserve fertility — and how is that decision made?
Fertility-preserving surgery is real for many germ cell tumours and some early-stage epithelial cancers. The conversation must happen before surgery, not after — and most general gynaecologists do not raise the option.
Will my first surgery be done by an oncology-trained surgeon — and why does that matter for ovarian cancer specifically?
The completeness of the first cytoreductive surgery is the single biggest predictor of ovarian cancer survival. A general gynaecologist operating on what turns out to be cancer often leaves residual disease behind, requiring a second larger surgery weeks later with worse outcomes.
Who will personally manage my case across surgery, treatment, and follow-up?
Ovarian cancer treatment spans surgery, chemotherapy, and often years of PARP inhibitor maintenance. The doctor who sees you across visits is the one most likely to catch what matters.
Will I get a written cost estimate covering everything — before treatment starts?
Ovarian cancer treatment is long and expensive. PARP inhibitor maintenance alone can run for 2–3 years. Diagnostics, surgery, chemotherapy, maintenance, and follow-up imaging can add up faster than patients expect.
How much time will I actually have to ask questions and understand my options?
A seven-minute consultation cannot honestly unpack an ovarian cancer diagnosis. Especially not in a second language, and especially when fertility, hereditary risk, and surgical approach all need to be discussed at the first visit.
Will my case be discussed by a team of specialists together, or decided by one person?
Ovarian cancer decisions cut across surgical and medical oncology, with input from radiation oncology, genetic counselling, and where relevant reproductive endocrinology. No single doctor sees the full picture alone.
We mean it: take this list to any consultation — ours or anyone else's. Mention the questions when you sit down with the doctor. A centre worth choosing will welcome them.
How CION Measures Up
Every standard below maps to a concern women carry into their first ovarian cancer consultation. We did not build these to look good on a webpage. We built them because they are what we would want if it were our family with the diagnosis.
Female specialists across every subspecialty
Dr. Paila Gowri Naidu (Surg Onc), Dr. Bharati Devi Gorantla (Med Onc), Dr. N. Kiranmayee (Med Onc), Dr. Venkata Sushma P (Rad Onc) — request a female specialist at booking.
45-minute first consultation
Six times the corporate-hospital default. Real time to understand your options.
Onco-trained surgical team — never general gynaecology
Every ovarian cancer surgery is performed by a surgical oncologist trained in complete cytoreduction, lymph node dissection, and omentectomy.
Fertility preservation discussed upfront
For young women, fertility-preserving surgery and reproductive options are part of the first consultation — not raised after surgery is over.
Multidisciplinary tumour board for every case
Surgical, medical, and radiation oncology — together — before any treatment decision.
Germline BRCA testing for every patient
Per current NCCN guidelines. Results inform PARP inhibitor eligibility and family screening.
Current PARP inhibitor maintenance protocols
Olaparib, niraparib, and rucaparib for BRCA-mutated and platinum-sensitive disease — current NCCN standard.
Structured NACT + interval debulking pathway
For advanced-stage patients unfit for upfront surgery — neoadjuvant chemo, re-staging, and interval debulking surgery.
One named lead specialist
From first consultation through surgery, chemotherapy, and follow-up. No rotating juniors.
Written, itemised cost estimate
Surgery, diagnostics, pathology, hospital, medicines, PARP inhibitor maintenance — quoted in writing before treatment begins.
Telugu · Hindi · English consultations
In the language you actually think in. Family members are encouraged to attend.
Free written second opinion
Documented. Yours to keep. Take it to any doctor, anywhere — including our competitors.
Every number above is independently verifiable on request — ask any CION specialist for the underlying details and they will give them to you.
How an Ovarian Cancer Case Actually Moves Through CION
From your first call to your final follow-up, here is how your case moves through CION.
First Consultation (45 minutes)
A senior oncologist — female if you have requested one — reviews your case in full. If you have a recent ultrasound, CT, or CA-125 result, we review what you already have. Family welcome. Telugu, Hindi, or English.
Diagnostic Review and Staging
Imaging and tumour markers are reviewed. If a tissue diagnosis is needed, options are discussed. For young women, fertility preservation is raised proactively at this stage — not after surgery. Germline genetic testing is offered for every patient.
Multidisciplinary Tumour Board Discussion
Your case is presented to surgical oncology, medical oncology, and where indicated radiation oncology — together — usually within five working days. Fertility, BRCA status, and family history are factored into the recommendation. The team's consensus is documented.
Treatment Plan with Named Lead Doctor
You meet your lead specialist. The full plan is explained in your preferred language — including the surgical approach, fertility implications, and likely chemotherapy and maintenance therapy. You receive a written, itemised cost estimate before anything begins.
Treatment
Primary debulking surgery, neoadjuvant chemotherapy with interval debulking, fertility-preserving surgery, adjuvant chemotherapy, or PARP inhibitor maintenance — delivered at one of 11 CION Hyderabad locations. The same lead doctor remains accountable for your case throughout.
Follow-Up and Surveillance
Ovarian cancer follow-up involves clinical review and CA-125 every 3 months for the first 2 years, with imaging where indicated. PARP inhibitor maintenance continues per protocol. Your lead doctor stays the same.
If at any stage you want a second opinion — internal or external — we facilitate it. Free, in writing, yours to keep.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Frequently Asked Questions
Who is the best ovarian cancer doctor in Hyderabad?
The best doctor depends on your stage and case complexity. For the initial surgery — which is the single most important decision in ovarian cancer treatment — look for an oncology-trained surgeon (surgical oncologist or gynaecologic oncologist) with documented experience in complete cytoreduction. For chemotherapy and PARP inhibitor maintenance, look for a medical oncologist current with NCCN protocols. At CION, every ovarian cancer case is reviewed by a multidisciplinary tumour board, with female specialists across surgical, medical, and radiation oncology for women who prefer them.
Should I see a gynaecologist or an oncologist for ovarian cancer?
Once ovarian cancer is suspected or diagnosed, treatment must be led by an oncologist — not a general gynaecologist. This is one of the most important points in ovarian cancer care: research consistently shows that women whose first surgery is performed by an oncology-trained surgeon have significantly better outcomes than those operated on by a general gynaecologist. A general gynaecologist remains an excellent doctor for routine reproductive health, but ovarian cancer surgery requires specific onco-surgical training in complete cytoreduction.
Can ovarian cancer treatment preserve my fertility?
Yes, in carefully selected cases — and this is one of the most important conversations to have at your first consultation. Fertility-preserving surgery (removing the affected ovary while leaving the uterus and the other ovary intact) is the standard of care for most germ cell ovarian tumours and an option for early-stage epithelial cancers in young women. The decision depends on cancer type, stage, and your personal goals. CION's tumour board specifically discusses fertility preservation for every young woman diagnosed with ovarian cancer.
Why does the first surgery matter so much in ovarian cancer?
The completeness of the initial cytoreductive surgery — how much of the visible tumour is removed at the first operation — is the single strongest predictor of long-term ovarian cancer survival. Women whose first surgery achieves complete cytoreduction (no visible residual disease) have meaningfully better outcomes than those left with residual tumour. This level of surgery requires onco-specific training in pelvic and abdominal anatomy, including omentectomy, lymph node dissection, and bowel surgery where needed — skills general gynaecologists are not trained in.
What is PARP inhibitor maintenance therapy?
PARP inhibitors (olaparib, niraparib, rucaparib) are oral targeted-therapy drugs that have transformed ovarian cancer survival in the past decade. After completing first-line chemotherapy, women with BRCA-mutated or platinum-sensitive ovarian cancer take a PARP inhibitor daily for up to 2–3 years to delay or prevent recurrence. Current NCCN guidelines recommend PARP inhibitor maintenance for most women with advanced ovarian cancer. CION delivers all current PARP inhibitor regimens.
Should I have genetic testing for ovarian cancer?
Yes. Current NCCN guidelines recommend germline genetic testing for every woman diagnosed with ovarian cancer, regardless of family history. Approximately 15–20% of ovarian cancers carry a BRCA1 or BRCA2 mutation, with additional cases linked to Lynch syndrome and other inherited mutations. Testing affects your treatment (BRCA-mutated cancers benefit specifically from PARP inhibitor maintenance) and has implications for family screening — your daughters and sisters may need testing too. CION includes genetic counselling and testing as part of every ovarian cancer pathway.
Are there female specialists for ovarian cancer at CION?
Yes. CION's ovarian cancer panel includes female specialists across all three subspecialties: Dr. Paila Gowri Naidu (M.Ch Surgical Oncology) leads our gynae-oncology surgical pathway; Dr. Bharati Devi Gorantla (DM Medical Oncology, Adyar) and Dr. N. Kiranmayee (DM Medical Oncology) lead chemotherapy and PARP inhibitor management; Dr. Venkata Sushma P (MD Radiation Oncology, SVIMS) provides radiation oncology where indicated. Women who prefer female specialists can request this when booking — we will arrange accordingly.
How do I get a second opinion before ovarian cancer surgery?
A second opinion is especially valuable before ovarian cancer surgery, particularly when surgery has been recommended by a general gynaecologist rather than an oncology-trained surgeon. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your imaging, CA-125, and any biopsy or referral notes, and provides a documented opinion you can take anywhere, including back to your original doctor.
How much does ovarian cancer treatment cost in Hyderabad?
Costs vary by stage and treatment. Primary debulking surgery ranges approximately ₹2,50,000 to ₹5,00,000 depending on complexity; six cycles of carboplatin-paclitaxel adjuvant chemotherapy adds ₹1,50,000 to ₹4,00,000; PARP inhibitor maintenance is significantly higher per month and continues for 1–3 years. For a detailed cost breakdown by treatment type, see our ovarian cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.
Can I choose a specific doctor for my ovarian cancer case at CION?
Yes. When booking your consultation, request a specific doctor by name — and if you prefer female specialists, please mention this so we can match you accordingly. Your chosen doctor becomes your named lead specialist for the duration of your care, while other panel specialists join for their part of the journey through the tumour board.
Take the next step with a team that does this every day
Onco-trained surgical team — never general gynaecology. Female specialists across surgical, medical, and radiation oncology. Fertility preservation discussed upfront. PARP inhibitor maintenance for BRCA-mutated and platinum-sensitive disease. Multidisciplinary tumour board for every patient. Free 45-minute consultation. NABH-accredited. Aarogyasri, EMI, and cashless insurance accepted.
This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.